Since JWH 018 is being created in such a way that it is eaten orally and has minimal to no security, it is assessed as being a program 1 material.As being a comprehensive agonist at the two the CB1 and CB2 cannabinoid receptors, this chemical compound is classed as an analgesic medication. The analgesic effects of cannabinoid ligands, mediated